1-4 of 4
Luca Giovanella
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma

Clinical Trials & Observations
Luca Ceriani, Lisa Milan, Maurizio Martelli, Andrés J. M. Ferreri, Luciano Cascione, Pier Luigi Zinzani, Alice Di Rocco, Annarita Conconi, Anastasios Stathis, Franco Cavalli, Monica Bellei, Kelly Cozens, Elena Porro, Luca Giovanella, Peter W. Johnson, Emanuele Zucca
Journal: Blood
Blood (2018) 132 (2): 179–186.
https://doi.org/10.1182/blood-2018-01-826958
Published: 2018
Includes: Supplemental data
Journal Articles

Limited Benefit of Additional Contrast-Enhanced CT to End-of- Treatment PET-CT Evaluation in Patients with Follicular Lymphoma

Gaetano Paone, MD, Mariana Raditchkova-Sarnelli, MD, Anastasios Stathis, Luca Giovanella, PhD, Emanuele Zucca, Luca Ceriani, MD
Journal: Blood
Blood (2016) 128 (22): 5925.
https://doi.org/10.1182/blood.V128.22.5925.5925
Published: 2016
Journal Articles

Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma

Clinical Trials & Observations
Luca Ceriani, Maurizio Martelli, Pier Luigi Zinzani, Andrés J. M. Ferreri, Barbara Botto, Caterina Stelitano, Manuel Gotti, Maria Giuseppina Cabras, Luigi Rigacci, Livio Gargantini, Francesco Merli, Graziella Pinotti, Donato Mannina, Stefano Luminari, Anastasios Stathis, Eleonora Russo, Franco Cavalli, Luca Giovanella, Peter W. M. Johnson, Emanuele Zucca
Journal: Blood
Blood (2015) 126 (8): 950–956.
https://doi.org/10.1182/blood-2014-12-616474
Published: 2015
Includes: Supplemental data
Journal Articles

Role of Positron Emission Tomography (PET/CT) in Primary Mediastinal Large B Cell Lymphoma (PMLBCL): Preliminary Results of an International Phase II Trial (IELSG-26 Study) Conducted On Behalf of the International Extranodal Lymphoma Study Group (IELSG), the Fondazione Italiana Linfomi (FIL) and the UK NCRI Lymphoma Group

Luca Ceriani, MD, Emanuele Zucca, MD, Pier Luigi Zinzani, MD, Andrés J.M. Ferreri, MD, Umberto Vitolo, MD, Caterina Stelitano, MD, Ercole Brusamolino, MD, Maria Giuseppina Cabras, MD, Luigi Rigacci, MD, Monica Balzarotti, MD, Flavia Salvi, MD, Graziella Pinotti, MD, Elena Porro, MSc, Erica Finolezzi, MD, Francesco Merli, MD, Chiara Rusconi, MD, Silvia Montoto, MD, Andrew Davies, MD, Paolo Paesano, MD, Armando Lopez-Guillermo, MD, Franco Cavalli, MD, Luca Giovanella, MD, Peter Johnson, Maurizio Martelli, MD
Journal: Blood
Blood (2012) 120 (21): 1566.
https://doi.org/10.1182/blood.V120.21.1566.1566
Published: 2012